MAPT and Alzheimer disease: Consistently, AD‐BDTOs triggered significantly greater LDH release compared to NDAN‐BDTOs, reinforcing that differences in tau oligomer structure may modulate their ability to disrupt cellular membranes and contribute to neuronal damage.